Latest Market News

Rhythm Biosciences has inked a non-exclusive distribution agreement with 4Cyte Pathology to integrate its ColoSTAT® colorectal cancer blood test into a vast pathology network across eastern Australia, aiming to boost adoption and accessibility.

BHP Group Limited reported a robust half-year to December 2025, with copper overtaking iron ore as the top earnings contributor and a detailed technical assessment released for its promising Vicuña copper-gold project.

Gateway Mining is set to begin a major drilling campaign at its Great Western prospect, following promising geological mapping that highlights a potentially significant gold system in Western Australia’s Yandal Gold Project.

SEEK Limited reported robust H1 FY2026 results, powered by AI-driven product innovation and pricing, delivering strong revenue and profit growth alongside a record interim dividend. However, a significant impairment on its Zhaopin investment weighed on reported earnings.

29Metals has successfully completed the retail portion of its entitlement offer, raising $31 million and finalising a $150 million capital injection to support its growth ambitions.

SEEK Limited has reported a robust first half for FY2026, driven by AI-enhanced products and strategic pricing, resulting in double-digit revenue growth and a record interim dividend.

SEEK Limited posted strong half-year revenue growth and record dividends, but a hefty impairment charge on its Chinese associate Zhaopin led to a significant net loss. The company’s strategic platform unification and Sidekicker reacquisition underpin operational momentum despite macroeconomic headwinds.

The Central Tanami Project joint venture between MGX Resources and Tanami Gold NL reports a 2.8 million ounce gold resource, progressing towards production with key infrastructure upgrades and exploration drilling underway.

Black Canyon Limited (ASX, BCA) has unveiled promising exploration results and positive scoping studies for its manganese and iron projects in Western Australia, positioning itself as a key emerging developer in the sector.

Sims Limited reported a 3.7% rise in half-year sales revenue to A$3.78 billion, propelled by strong non-ferrous prices and robust growth in its Lifecycle Services division. Underlying EBIT soared 65.9%, reflecting strategic acquisitions and operational efficiencies despite challenging ferrous markets.

Sims Limited reported a robust fiscal 2026 half-year underlying profit, boosted by strong performances in its Lifecycle Services and North American metal operations. Despite statutory losses from derivative impacts, the company declared a healthy interim dividend and outlined strategic investments for future growth.

Tetratherix Limited reveals promising interim results for TetraDerm, its scar prevention product, showing minimal scarring in patients after skin lesion surgeries. The product’s unique approach could reshape wound closure in a $US2.1 billion market.